My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
July/August 2010
Policy and Advocacy
FDA, NIAID, and IDSA Hold Antibacterial Resistance Workshop
Video and slide presentations available online

Researchers, physicians, regulators, government officials, and industry representatives came together at a joint workshop last month to discuss the science around antibacterial resistance and new drug and related diagnostics development.

Co-sponsored by IDSA, the Food and Drug Administration (FDA), and the National Institute of Allergy and Infectious Diseases (NIAID), the two-day, public workshop included keynote presentations by NIAID Director Anthony Fauci, MD, FIDSA, and FDA Principal Deputy Commissioner Joshua Sharfstein, MD.  

The workshop, held July 26-27 in Silver Spring, Md., was well attended, and 160 users viewed a live webcast available through IDSA’s website. Videos of presentations and accompanying slides are available for free on IDSA’s website.

A follow-up report from IDSA will summarize highlights and make recommendations for additional research. The workshop featured presentations and question-and-answer sessions focused on four key areas:

  • scale of the current antibacterial resistance problem
  • science and mechanisms of bacterial resistance
  • science of development of rapid diagnostics
  • science of antibacterial drug development

IDSA called on Congress in April to substantially increase NIAID’s funding for antibacterial resistance and drug discovery and development research, and also asked lawmakers to significantly increase FDA’s budget for antimicrobial resistance and antibiotic drug review programs (see IDSA’s congressional testimony).

How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
EIN Update: When to Stop Inpatient Antibiotic Treatment
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Health Reform Law Brings Possible Medicare Payment Changes
Global ID
Five Lessons from the International AIDS Conference
HIVMA and NIH Selected as Local Scientific Partners for AIDS 2012
Policy and Advocacy
National HIV/AIDS Strategy Released
FDA, NIAID, and IDSA Hold Antibacterial Resistance Workshop
Hearing Highlights Need to Curb Antibiotic Use on the Farm
IDSA Urges CDC to Support Mandatory Influenza Vaccination for HCWs
Supreme Court to Hear Vaccine Compensation Case
Your Colleagues
Vote for the IDSA and HIVMA Boards of Directors
Congratulations, New IDSA Fellows!
Welcome, New Members!
Education & Resources
Redesigned ID/HIV Career Center Offers New Features
IAC Offers Adult Immunization Screening Tool
Top Stories
From the President: Preparing for Influenza
HHS Announces Final Rules on ‘Meaningful Use’ of Electronic Health Records
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.